Recall of Children’s BENADRYL® Allergy FASTMELT® Tablets and Junior Strength MOTRIN® Caplets

http://www.fda.gov/Safety/Recalls/ucm235002.htm

 

Asthma Drugs associated with risk of severe worsening of asthma symptoms

The U.S. Food and Drug Administration today announced that drugs in the class of long-acting beta agonists (LABAs) should never be used alone in the treatment of asthma in children or adults. Manufacturers will be required to include this warning in the product labels of these drugs, along with taking other steps to reduce the overall use of these medications.

These new requirements are based on FDA analyses of clinical trials showing that use of these long-acting medicines is associated with an increased risk of severe worsening of asthma symptoms, leading to hospitalization in both children and adults and death in some patients with asthma…………

FDA Warning